Principia Wealth Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Principia Wealth Advisory's AZN Position: Q2 2026 in Review
Principia Wealth Advisory increased its AstraZeneca (AZN) stake by 44% in Q2 2026, buying an estimated $8.84K and bringing the position to 153 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #154.
Principia Wealth Advisory first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Principia Wealth Advisory held 153 shares of AstraZeneca worth $29K as of Q2 2026.
- Principia Wealth Advisory bought 47 AstraZeneca shares in Q2 2026, an estimated $8.84K.
- AstraZeneca made up 0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #154 holding.
- Principia Wealth Advisory first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
- 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.